Get started
Spyre Therapeutics, Inc.SS

Spyre Therapeutics, Inc.

19.49USDR
−1.01−4.93%
At close at Mar 7, 22:58 GMT
USD
No trades
See on Supercharts
Overview
Financials
News Discussions Technicals Forecast Seasonals Options
Back

Cash from financing activities of Spyre Therapeutics, Inc.

Annual data
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
TTM
‪0.00‬
‪‪110.00 M‬‬
‪‪220.00 M‬‬
‪‪330.00 M‬‬
‪‪440.00 M‬‬
Period
Value
Change
Change %
TTM
‪‪411.31 M‬‬
‪0.00‬
‪0.00‬%
2024
‪‪411.31 M‬‬
+‪‪50.24 M‬‬
+‪13.91‬%
2023
‪‪361.08 M‬‬
+‪‪318.40 M‬‬
+‪746.05‬%
2022
‪‪42.68 M‬‬
+‪‪41.28 M‬‬
+‪‪2.96 K‬‬%
2021
‪‪1.39 M‬‬
‪‪−153.12 M‬‬
‪−99.10‬%
2020
‪‪154.51 M‬‬
+‪‪88.79 M‬‬
+‪135.10‬%
2019
2018
2017
2016
2015
Quarterly data
Q2 '17
Q3 '17
Q4 '17
Q1 '18
Q2 '18
Q3 '18
Q4 '18
Q1 '19
Q2 '19
Q3 '19
Q4 '19
Q1 '20
Q2 '20
Q3 '20
Q4 '20
Q1 '21
Q2 '21
Q3 '21
Q4 '21
Q1 '22
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
‪‪−80.00 M‬‬
‪0.00‬
‪‪80.00 M‬‬
‪‪160.00 M‬‬
‪‪240.00 M‬‬
Period
Value
Change
Change %
Q4 '24
‪‪225.93 M‬‬
+‪‪213.07 M‬‬
+‪‪1.66 K‬‬%
Q3 '24
‪‪12.86 M‬‬
+‪‪12.50 M‬‬
+‪‪3.47 K‬‬%
Q2 '24
‪‪360.00 K‬‬
‪‪−171.81 M‬‬
‪−99.79‬%
Q1 '24
‪‪172.16 M‬‬
+‪‪8.56 M‬‬
+‪5.23‬%
Q4 '23
‪‪163.61 M‬‬
+‪‪176.14 M‬‬
—
Q3 '23
‪‪−12.53 M‬‬
‪‪−222.52 M‬‬
‪−105.97‬%
Q2 '23
‪‪209.99 M‬‬
+‪‪209.98 M‬‬
+‪‪2.10 M‬‬%
Q1 '23
‪‪10.00 K‬‬
+‪‪18.00 K‬‬
—
Q4 '22
Q3 '22
Q2 '22
Q1 '22
Q4 '21
Q3 '21
Q2 '21
Q1 '21
Q4 '20
Q3 '20
Q2 '20
Q1 '20
Q4 '19
Q3 '19
Q2 '19
Q1 '19
Q4 '18
Q3 '18
Q2 '18
Q1 '18
Q4 '17
Q3 '17
Q2 '17